Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2013-09-30 Earnings Release
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec receives clinical milestone as part of its discovery alliance with Boehringer Ingelheim
Earnings Release Classification · 99% confidence The document is a short press release dated September 30, 2013, announcing a specific clinical milestone achieved in a research alliance with Boehringer Ingelheim, resulting in a revenue trigger of EUR 2.0m for Evotec. It contains standard corporate news elements, including forward-looking statements and contact information, and is disseminated via DGAP. This type of announcement, focusing on a specific operational or financial event (like a milestone payment) rather than comprehensive periodic results (like 10-K or IR), is best classified as a general corporate news item. Since it is not a formal regulatory filing like a 10-K, nor a specific announcement like a dividend (DIV) or management change (MANG), it falls under the general regulatory announcement category, which is RNS, as it is a 'Corporate News' disseminated through a service that handles regulatory announcements. Q3 2013
2013-09-30 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details a correction regarding the notification of voting rights exceeding a threshold (3%) in Evotec AG, referencing Article 21 of the WpHG (German Securities Trading Act). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes and related announcements, including changes in significant share ownership thresholds.
2013-09-19 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details the crossing of ownership thresholds (5% and 10%) by a notifier (TVM V Life Science Ventures GmbH & Co. KG) in Evotec AG, referencing specific German securities trading act articles (Art. 25a, Sec. 1 WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'.
2013-09-18 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details a notification pursuant to Article 21, Section 1 of the WpHG (German Securities Trading Act) regarding a change in voting rights crossing the 3% threshold by Deutsche Asset & Wealth Management Investment GmbH. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a regulatory announcement, DVA is a more specific category than the general RNS.
2013-09-18 English
Evotec and Harvard Stem Cell Institute form CureMN collaboration to advance ALS research
Regulatory Filings Classification · 100% confidence The document is a press release dated September 12, 2013, announcing a strategic partnership between Evotec AG and the Harvard Stem Cell Institute (HSCI) to advance ALS research. It details the collaboration ('CureMN'), quotes executives, and provides background information on ALS, Evotec, HSCI, and related entities. This type of announcement, detailing a business development or strategic alliance, does not fit the specific financial reporting categories (10-K, IR, ER, etc.). It is a general corporate news release concerning operations and strategy. Since it is not a formal regulatory filing like a Director's Dealing (DIRS) or a Capital Change (CAP), and it is not an announcement of a report (RPA), the most appropriate general category for significant corporate news that doesn't fit elsewhere is 'Regulatory Filings' (RNS), which often serves as a catch-all for press releases disseminated via regulatory channels (like DGAP mentioned at the end).
2013-09-12 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details multiple instances where various entities (BVF Inc., BVF Investments, L.L.C., etc.) exceeded specific voting rights thresholds (3% and 5%) in Evotec AG, citing German Securities Trading Act (WpHG) articles (Article 26, Section 1, Article 21, Section 1, Article 22). This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which maps to the Major Shareholding Notification (MRQ) category. Although the header mentions 'Voting Rights Announcements', the content is a notification of crossing ownership thresholds, which is best classified as MRQ based on the provided definitions. It is not a Director's Dealing (DIRS) as it concerns institutional/investor holdings, not necessarily director transactions, and it is not a general Regulatory Filing (RNS) because a more specific category exists.
2013-09-09 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.